ASTH Key Statistics, Chart & Performance
The current stock price of ASTH is 22.5 USD. In the past month the price decreased by -32.43%. In the past year, price decreased by -46.57%.
ASTH Latest News, Press Relases and Analysis
ASTH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.39 | 98.97B | ||
| CI | THE CIGNA GROUP | 9.79 | 74.29B | ||
| LH | LABCORP HOLDINGS INC | 16.79 | 22.02B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.6 | 21.39B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 108.86 | 19.67B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.58B | ||
| DVA | DAVITA INC | 13.03 | 8.60B | ||
| HIMS | HIMS & HERS HEALTH INC | 64.28 | 7.85B | ||
| CHE | CHEMED CORP | 20.08 | 6.44B | ||
| RDNT | RADNET INC | 218.42 | 6.38B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.91 | 6.13B | ||
| OPCH | OPTION CARE HEALTH INC | 19.85 | 4.80B |
Related stock screener links
About ASTH
Company Profile
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
Company Info
ASTRANA HEALTH INC
1668 S. Garfield Avenue, 2Nd Floor
Alhambra CALIFORNIA US
Employees: 1900
Phone: 16262820288
ASTRANA HEALTH INC / ASTH FAQ
Can you describe the business of ASTRANA HEALTH INC?
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
What is the current price of ASTH stock?
The current stock price of ASTH is 22.5 USD. The price increased by 10.62% in the last trading session.
Does ASTRANA HEALTH INC pay dividends?
ASTH does not pay a dividend.
How is the ChartMill rating for ASTRANA HEALTH INC?
ASTH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting ASTH stock to perform?
16 analysts have analysed ASTH and the average price target is 43.22 USD. This implies a price increase of 92.1% is expected in the next year compared to the current price of 22.5.
Can you provide the growth outlook for ASTRANA HEALTH INC?
The Revenue of ASTRANA HEALTH INC (ASTH) is expected to grow by 61.55% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the ownership details for ASTH stock?
You can find the ownership structure of ASTRANA HEALTH INC (ASTH) on the Ownership tab.
ASTH Technical Analysis
ASTH Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ASTH. There are concerns on the financial health of ASTH while its profitability can be described as average.
ASTH Financial Highlights
Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -85.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.33% | ||
| ROA | 0.43% | ||
| ROE | 1.23% | ||
| Debt/Equity | 1.29 |
ASTH Forecast & Estimates
16 analysts have analysed ASTH and the average price target is 43.22 USD. This implies a price increase of 92.1% is expected in the next year compared to the current price of 22.5.
For the next year, analysts expect an EPS growth of 37.27% and a revenue growth 61.55% for ASTH